Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED BALANCE SHEETS

v3.10.0.1
CONSOLIDATED BALANCE SHEETS - USD ($)
Oct. 31, 2018
Oct. 31, 2017
Current assets:    
Cash and cash equivalents $ 3,055,890 $ 3,339,374
Short–term investments in certificates of deposit 2,000,000 3,500,000
Prepaid expenses and other current assets 482,482 174,566
Total current assets 5,538,372 7,013,940
Patents, net of impairment of $582,979 in 2018 and accumulated amortization of $1,615,632 and $1,290,336, respectively 837,500 1,745,775
Property and equipment, net of accumulated depreciation of $53,799 and $35,725, respectively 72,670 52,701
Total assets 6,448,542 8,812,416
Current liabilities:    
Accounts payable 582,012 480,324
Accrued expenses 683,099 409,169
Total current liabilities 1,265,111 889,493
Commitments and contingencies (Note 6 and 7)
Shareholders’ equity:    
Preferred stock, par value $100 per share; 19,860 shares authorized; no shares issued or outstanding and Series A convertible preferred stock, par value $100 per share; 140 shares authorized; no shares issued or outstanding
Common stock, par value $.01 per share; 48,000,000 and 24,000,000 shares authorized, respectively; 18,908,632 and 16,602,759 shares issued and outstanding, respectively 189,086 166,028
Additional paid-in capital 175,415,931 163,931,079
Accumulated deficit (170,170,209) (156,174,184)
Total shareholders’ equity 5,434,808 7,922,923
Noncontrolling interest (Note 2) (251,377)
Total equity 5,183,431 7,922,923
Total liabilities and equity 6,448,542 8,812,416
Series A Preferred Stock [Member]    
Shareholders’ equity:    
Preferred stock, par value $100 per share; 19,860 shares authorized; no shares issued or outstanding and Series A convertible preferred stock, par value $100 per share; 140 shares authorized; no shares issued or outstanding
Preferred Stock [Member]    
Shareholders’ equity:    
Preferred stock, par value $100 per share; 19,860 shares authorized; no shares issued or outstanding and Series A convertible preferred stock, par value $100 per share; 140 shares authorized; no shares issued or outstanding